ODANACATIB TREATMENT OF POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY: 3-YEAR CONTINUED THERAPY AND RESOLUTION OF EFFECT

被引：0
|
作者：
Rizzoli, R. [1 ]
Eisman, J. A. [2 ]
Bone, H. [3 ]
Hosking, D. [4 ]
McClung, M. [5 ]
Reid, I. [6 ]
Resch, H. [7 ]
Verbruggen, N. [8 ]
Santora, A. [9 ]
Hustad, C. [9 ]
Lombardi, A. [9 ]
机构：
[1] Univ Hosp Cantonal, Geneva, Switzerland
[2] St Vincents Hosp, Garvan Inst Med Res, Sydney, NSW 2010, Australia
[3] Michigan Bone & Mineral Ctr, Detroit, MI USA
[4] City Hosp Nottingham, Nottingham, England
[5] Oregon Osteoporosis Ctr, Portland, OR USA
[6] Univ Auckland, Auckland 1, New Zealand
[7] St Vincents Hosp, Vienna, Austria
[8] Merck Res Labs, Brussels, Belgium
[9] Merck Res Labs, Rahway, NJ USA
来源：
OSTEOPOROSIS INTERNATIONAL | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：27 / 27
页数：1
相关论文
共 50 条
  • [1] Odanacatib in the Treatment of Postmenopausal Women with Low Bone Mineral Density: 3-Year Continued Therapy and Resolution of Effect
    Reid, Ian
    Eisman, John
    Bone, Henry
    Hosking, David
    McClung, Michael
    Rizzoli, Rene
    Resch, Heinrich
    Verbruggen, Nadia
    Hustad, Carolyn
    DaSilva, Carolyn
    Santora, Arthur
    Ince, Avery
    Lombardi, Antonio
    BONE, 2010, 46 : S31 - S32
  • [2] Odanacatib in the Treatment of Postmenopausal Women With Low Bone Mineral Density: Three-Year Continued Therapy and Resolution of Effect
    Eisman, John A.
    Bone, Henry G.
    Hosking, David J.
    McClung, Michael R.
    Reid, Ian R.
    Rizzoli, Rene
    Resch, Heinrich
    Verbruggen, Nadia
    Hustad, Carolyn M.
    DaSilva, Carolyn
    Petrovic, Romana
    Santora, Arthur C.
    Ince, B. Avery
    Lombardi, Antonio
    JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (02) : 242 - 251
  • [3] Odanacatib in the Treatment of Postmenopausal Women With Low Bone Mineral Density: Five Years of Continued Therapy in a Phase 2 Study
    Langdahl, Bente
    Binkley, Neil
    Bone, Henry
    Gilchrist, Nigel
    Resch, Heinrich
    Portales, Jose Rodriguez
    Denker, Andrew
    Lombardi, Antonio
    De Tilleghem, Celine Le Bailly
    DaSilva, Carolyn
    Rosenberg, Elizabeth
    Leung, Albert
    JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (11) : 2251 - 2258
  • [4] EFFECT OF ODANACATIB ON BONE DENSITY AND BONE TURNOVER MARKERS IN POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY: YEAR 4 RESULTS
    Eisman, J. A.
    Binkley, N.
    Bone, H.
    Hosking, D.
    Langdahl, B.
    Reid, I.
    Resch, H.
    Rodriguez Portales, J.
    De Tilleghem, C. Le Bailly
    Hustad, C.
    DaSilva, C.
    Santora, A.
    Denker, A.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : S526 - S526
  • [5] Effect of Odanacatib on Bone Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mineral Density: Year 4 Results
    Leung, Albert
    Petrovic, Romana
    DaSilva, Carolyn
    Rosenberg, Elizabeth
    Santora, Arthur
    Lombardi, Antonio
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1179 - 1180
  • [6] Odanacatib treatment in postmenopausal women with low bone mineral density: 24-month results
    McClung, M.
    Eisman, J. A.
    Bone, H. G.
    Roux, C.
    Recker, R. R.
    Verbruggen, N.
    Hustad, C. M.
    daSilva, C.
    Kimmel, D.
    Santora, A.
    Ince, A.
    BONE, 2009, 44 (02) : S438 - S438
  • [7] Odanacatib in postmenopausal women with low bone mineral density: a review of current clinical evidence
    Zerbini, Cristiano A. F.
    McClung, Michael R.
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2013, 5 (04) : 199 - 209
  • [8] Results from a 3-year study designed to evaluate the effect of sodium on bone mineral density in postmenopausal women
    不详
    CALCIFIED TISSUE INTERNATIONAL, 2006, 78 : S140 - S141
  • [9] EIGHT YEARS OF CONTINUED ODANACATIB THERAPY FOR POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY: RESULTS FROM AN OPEN-LABEL EXTENSION TO A PHASE IIB STUDY
    Rizzoli, R.
    Rodriguez Portales, J. A.
    Benhamou, C. L.
    Halse, J.
    Miller, P. D.
    Reid, I.
    Dasilva, C.
    Kroon, R.
    Leung, A.
    Gurner, D.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S123 - S124
  • [10] Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 study
    Rizzoli, R.
    Benhamou, C. -L.
    Halse, J.
    Miller, P. D.
    Reid, I. R.
    Rodriguez Portales, J. A.
    DaSilva, C.
    Kroon, R.
    Verbruggen, N.
    Leung, A. T.
    Gurner, D.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 (06) : 2099 - 2107
12345